TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
It’s not just the efficacy and safety of the produ... See more
Dec, 30, 2022
The analyst comments "TGTX stock is up >15... See more
Mar, 22, 2023
$COST almost!
Mar, 22, 2023
$COST this dude 🤡🤣🤣🤣
Mar, 22, 2023
$COST The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.
Mar, 21, 2023
$COST 💵long 💅
Mar, 20, 2023
$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
Mar, 20, 2023
$COST nice wedge here 🫡🔒 all I gottta say 🤫
Mar, 18, 2023
$COST Love Costco as much as anyone
Mar, 17, 2023
$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy
Mar, 16, 2023
$COST The chart points towards an optimistic outlook for the stock.
Mar, 15, 2023
$COST Always a buy in the 470s, congratulations to those who got it this a.m.
Feb, 4, 2023
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Feb, 6, 2023
costs nothing to hold ladies.
Feb, 6, 2023
however, Tesla is 3% with substantially less cost to borrow.
Feb, 5, 2023
Buy and hold until you’re happy w your cost basis
Feb, 1, 2023
Your cost is now lower as well 😂.
Jan, 26, 2023
Cost down to $28.73… Will keep buying til I cant afford the stock price. lol
Jan, 26, 2023
Got my cost down to $29.61.
Jan, 20, 2023
Improved supply chain means lower costs and higher margins.
Jan, 8, 2023
SSR + High Cost to Borrow + High FTDs due on 11th (over $1 million) + Trending = GOOD CHANCE FOR NICE PRICE POP💰💰💰 https://www.warriortrading.com/short-sale-restriction-ssr-fast-explanation/
Jan, 7, 2023
$HKD Cost to borrow rapidly increasing now at 221% only 60K shares awailable, primed to run next week 🚀🚀🚀🚀🚀🚀🚀
Nov, 4, 2022
$HKD had to take some $ on the run up and buy back lower - feeling pretty good now with a cost basis of 20$ - next run should be massive IMO 🫡